 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 289
Date: July 28, 2024
Today I would like to tell you about a brand new clinical trial that has already launched at the University of Minnesota, one that might give patients a shot at getting the much desired graft-versus-leukemia (GVL), while steering clear of the dreaded Graft-versus-host disease (GVHD). The good news is that CLL patients are eligible for this trial. I am so impressed by the concept of this trial and its potential that we have decided to fund part of the cost of this trial with your generous and precious dollar donations. Right there is a strong vote of confidence, our good housekeeping seal of approval as it were.
The science is pretty cool, and in our latest full length article on clltopics.org I have done my best to give you a clear picture of what is involved. Late stage patients who cannot get a transplant because they do not have HLA matched siblings or matched unrelated donors may find this trial a very good option to consider – provided they have at least one biologic child of their own who is wiling to help.
I am back at work. I have been a workaholic my whole adult life and this is the only way I know how to deal with PC’s death. PC was our webmaster, editor, publisher and all round tech expert. His absence is felt keenly as we try to go forward with this mission that was so close to his heart. Stepping into the breach as our new webmaster is our daughter Radha Venkat. I may be a teeny bit biased, but I think she truly represents the best of both of her parents.
Radha is a little unsure of herself as she makes her debut with this first full length article published since PC passed away. After all, she has some pretty big shoes to fill. She asked me to ask you to bring any glitches in this article (as well as future articles) to her attention, so that she can fix them. She can be reached at 
.
Be well,
Chaya
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
